跳至主要内容
临床试验/NCT05963555
NCT05963555已完成不适用

Evaluation of Photobiomodulation or Dry Float Therapy on Sleep Quality in Middle-aged and Elderly Individuals.

West Virginia University2 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2023年7月31日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
15
试验地点
2
主要终点
Changes in total sleep via Oura Ring

研究概览

简要总结

The main objective of this study is to assess the impact of implementing photobiomodulation (PBM) therapy, either localized or whole body, or dry float on sleep quality in middle-aged and elderly individuals experiencing sleep disturbance. As a secondary objective we will analyze the effect of the treatments on other indices of recovery (subjective and objective) via physiological monitoring in middle-aged and elderly individuals experiencing sleep disturbance.

The study will have 2 phases: Phase 1 will last 5 weeks and will serve as baseline data collection of sleep quality. Phase 2 contains the experimental conditions and will last 13 weeks. Cognitive, behavioral, and physiological tests will be done at baseline (week 1) and at the end of experimental period (week 18). Sleep tracking data will be collected daily.

详细描述

In summary the study participants are expected to:

  • Wear a study provided smart ring (OURA Ring) through the end of the study period (at least 75% of the total study time) which measures sleep quantity/quality.
  • Keep their smart phones nearby and charged while wearing their devices.
  • Complete monthly surveys with questions about general well-being until the end of the study period.
  • Complete a testing battery consisting of cognitive tests, behavioral and mood questionnaires, qEEG and physical assessments, in the beginning and at the end of the study period.
  • Complete the designated experimental condition 2- 3x/week for 12 weeks (at least 75% of the total sessions), if applicable.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

入排标准

年龄范围
50 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female between 50-85 years of age
  • Able and willing to give informed consent
  • No significant untreated medical history

排除标准

  • Have no mental or physical conditions that are deemed inappropriate for study participation at investigator's discretion.

研究组 & 干预措施

Whole-Body Photobiomodulation

Experimental

Light therapy in both the visible and near-infrared range (non-UV) applied to the whole body in a light pod or bed.

干预措施: NovoThor (Device)

Dry Float

Experimental

Simulates the effects of traditional Float-REST therapy. Instead of contact with salt water, the dry float system has a very thin membrane that cradles the body and provides a warm sensation, similar to that experienced in a traditional flotation tank.

干预措施: ZeroBody (Device)

Localized Photobiomodulation

Experimental

Light therapy in both the visible and near-infrared range (non-UV) applied locally to only a specific body region.

干预措施: VieLight (Device)

Control

No Intervention

Participants in the control group will be asked to keep their normal daily routine.

结局指标

主要结局

Changes in total sleep via Oura Ring

时间窗: Changes from baseline versus end of study week 18

Oura Ring will be used to track total sleep throughout the study. Increased total sleep values will indicate better quality sleep and decrease total sleep values will indicate poorer sleep.

Changes in resting state electroencephalography (EEG)

时间窗: Changes from baseline versus end of study week 18

Electroencephalography (EEG) analysis looking for alterations in brain activity. A paired samples t-Test will be used to compare power activity at baseline and follow-up.

Changes in the Circadian Sleep Inventory

时间窗: Changes from baseline versus end of study week 18

Evaluate changes in the participants sleeping patterns. Higher values indicate poorer sleep quality.

Changes in the Patient Health Questionnaire (PHQ-9)

时间窗: Changes from baseline versus end of study week 18

Participants will complete the Patient Health Questionnaire (PHQ-9) once a month. The higher the score, the more severe the symptoms of depression. Scores range from 5-9 = mild, 10-14 = moderate, 15-19 = moderate severe, 20-27 severe depression

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验